2025-04-01 04:08:00
Latest Post
Infosys and Linux Foundation Networking Collaborate to Strengthen Responsible AI for Global Networks
ITC announces strategic acquisition of Pulp & Paper Undertaking of Aditya Birla Real Estate Limited
AGI Greenpac Ltd approves ~ Rs. 700 crore capex
NHPC Ltd updates on 300 MW Bikaner Solar Power Project
Prashant India Ltd enters into agreement for sale with Shantilon Poly Pvt Ltd
Stock Report
Zim Laboratories Ltd posts consolidated PAT of Rs. 3.25 crore in Q2FY22
Posted On : 2021-11-04 17:50:59( TIMEZONE : IST )
Zim Laboratories Ltd has reported Consolidated financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 78.3418 crores during the period ended September 30, 2021 as compared to Rs. 65.3961 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 3.2588 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 0.1887 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 2 for the period ended September 30, 2021 as compared to Rs. 0.12 for the period ended June 30, 2021.
| Financials | Q2 FY2022 | Q1 FY2022 | % Change |
| Total Income | ₹ 78.3418 crs | ₹65.3961 crs |  19.80% |
| Net Profit | ₹3.2588 crs | ₹0.1887 crs | 1,626.97% |
| EPS | ₹2 | ₹0.12 | 1,566.67% |
Financial Results (Q2 FY2022) - YoY Comparison
The company has reported total income of Rs. 78.3418 crores during the period ended September 30, 2021 as compared to Rs.88.2209 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.3.2588 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.1.1948 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.2 for the period ended September 30, 2021 as compared to Rs.0.73 for the period ended September 30, 2020.
| Financials | Q2 FY2022 | Q2 FY2021 | % Change |
| Total Income | ₹ 78.3418 crs | ₹88.2209 crs |  -11.20% |
| Net Profit | ₹3.2588 crs | ₹1.1948 crs | 172.75% |
| EPS | ₹2 | ₹0.73 | 173.97% |
Financial Results (Half Year Ended FY2022) - YoY Comparison
The company has reported total income of Rs.143.7379 crores during the 6 Months period ended September 30, 2021 as compared to Rs.159.3212 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.3.4475 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.4.4756 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.2.12 for the 6 Months period ended September 30, 2021 as compared to Rs.2.75 for the 6 Months period ended September 30, 2020.
| Financials | Half Year Ended FY2022 | Half Year Ended FY2021 | % Change |
| Total Income | ₹143.7379 crs | ₹159.3212 crs | -9.78% |
| Net Profit | ₹3.4475 crs | ₹4.4756 crs | -22.97% |
| EPS | ₹2.12 | ₹2.75 | -22.91% |
Shares of Zim Laboratories Ltd was last trading in BSE at Rs. 130.90 as compared to the previous close of Rs. 130.20. The total number of shares traded during the day was 4535 in over 64 trades.
The stock hit an intraday high of Rs. 136.70 and intraday low of 128.50. The net turnover during the day was Rs. 601211.00.
